***** To join INSNA, visit http://www.insna.org *****
Dr. Conover, a chemist, developed tetracycline, a powerful chemically altered antibiotic with fewer side effects than the drug from which it was derived.
A footnote: this is what was tracked in the landmark Coleman, Katz, Menzel, "Doctors and New Drugs". Originally done under a contract with Pfizer, the name of the drug was disguised. A classic example of Lazersfeld turning commercial proprietary research into academically respectable research.
SOCNET is a service of INSNA, the professional association for social
network researchers (http://www.insna.org). To unsubscribe, send
an email message to [log in to unmask] containing the line
UNSUBSCRIBE SOCNET in the body of the message.